Mohr, B., Oelschlaegel, U., Thiede, C., Stewart, M. M., Ehninger, G., & Platzbecker, U. (2009). The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34(+) progenitor cells. Ferrata Storti Foundation.

Mohr, Brigitte, Uta Oelschlaegel, Christian Thiede, Michelle Meredyth Stewart, Gerhard Ehninger, and Uwe Platzbecker. The Response to Lenalidomide of Myelodysplastic Syndrome Patients With Deletion Del(5q) Can Be Sequentially Monitored in CD34(+) Progenitor Cells. Ferrata Storti Foundation, 2009.

Mohr, Brigitte, et al. The Response to Lenalidomide of Myelodysplastic Syndrome Patients With Deletion Del(5q) Can Be Sequentially Monitored in CD34(+) Progenitor Cells. Ferrata Storti Foundation, 2009.